Literature DB >> 15486995

Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.

Colm Morrissey1, Amanda O'Neill, Barbara Spengler, Volker Christoffel, John M Fitzpatrick, R William G Watson.   

Abstract

BACKGROUND: Phytoestrogens may reduce tumorigenesis in prostate cancer. We screened five phytoestrogens for their effect on cell growth and apoptosis in PWR-1E, LNCaP, PC-3, and DU145 prostate epithelial cells in vitro.
METHODS: We assessed cell number, proliferation, and apoptosis using crystal violet assays, flow cytometric analysis, and TUNEL. Focusing specifically on apigenin we assessed the ability of calpain, serine protease, caspase, estrogen receptor, and ceramide synthase inhibitors to block apigenin induced apoptosis. We also analyzed caspase 3, 7, 8, 9, Bcl-2, Bax, Bid, and cytochrome C by Western analysis, and mitochondrial permeability and reactive oxygen species production by flow cytometry using mitosensor(TM) and DCFH-DA, respectively.
RESULTS: Apigenin and silybinin significantly reduced cell number, with apigenin inducing apoptosis in PWR-1E, LNCaP, PC-3, and DU145 cells. The PC-3 and DU145 cells were less susceptible to apigenin induced apoptosis then LNCaP and PWR-1E cells. The induction of apoptosis by apigenin was caspase dependent. Apigenin generated reactive oxygen species, a loss of mitochondrial Bcl-2 expression, mitochondrial permeability, cytochrome C release, and the cleavage of caspase 3, 7, 8, and 9 and the concomitant cleavage of the inhibitor of apoptosis protein, cIAP-2. The overexpression of Bcl-2 in LNCaP B10 cells reduced the apoptotic effects of apigenin.
CONCLUSIONS: Apigenin induces cell death in prostate epithelial cells using a mitochondrial mediated cell death pathway. Bcl-2 has a role in inhibiting apigenin induced cell death in prostate epithelial cells. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15486995     DOI: 10.1002/pros.20167

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  17 in total

1.  The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus.

Authors:  Matthew Dean; Julia Austin; Ren Jinhong; Michael E Johnson; Daniel D Lantvit; Joanna E Burdette
Journal:  Horm Cancer       Date:  2018-05-07       Impact factor: 3.869

2.  Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells.

Authors:  Rajeshwari H Patil; R L Babu; M Naveen Kumar; K M Kiran Kumar; Shubha M Hegde; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Mol Cell Biochem       Date:  2015-02-10       Impact factor: 3.396

Review 3.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

4.  Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo.

Authors:  Amit Budhraja; Ning Gao; Zhuo Zhang; Young-Ok Son; Senping Cheng; Xin Wang; Songze Ding; Andrew Hitron; Gang Chen; Jia Luo; Xianglin Shi
Journal:  Mol Cancer Ther       Date:  2011-11-14       Impact factor: 6.261

5.  Apigenin suppresses cancer cell growth through ERbeta.

Authors:  Paul Mak; Yuet-Kin Leung; Wan-Yee Tang; Charlotte Harwood; Shuk-Mei Ho
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

Review 6.  Apigenin: a promising molecule for cancer prevention.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

7.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

8.  Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells.

Authors:  Ivana Vrhovac Madunić; Josip Madunić; Maja Antunović; Mladen Paradžik; Vera Garaj-Vrhovac; Davorka Breljak; Inga Marijanović; Goran Gajski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-14       Impact factor: 3.000

Review 9.  Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis.

Authors:  Bharat B Aggarwal; Michelle E Van Kuiken; Laxmi H Iyer; Kuzhuvelil B Harikumar; Bokyung Sung
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

10.  Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.

Authors:  Surajit Karmakar; Kristin A Davis; Subhasree Roy Choudhury; Anurag Deeconda; Naren L Banik; Swapan K Ray
Journal:  Biochem Biophys Res Commun       Date:  2009-08-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.